Rules of Medical Necessity

Amy B. Monahan, D. Schwarcz
{"title":"Rules of Medical Necessity","authors":"Amy B. Monahan, D. Schwarcz","doi":"10.2139/SSRN.3777505","DOIUrl":null,"url":null,"abstract":"Health insurance contracts have long excluded coverage for care that is “experimental” or not “medically necessary.” Historically, insurance policies defined these key terms of coverage using broad standards. For example, “medically necessary” care might be defined as care that is “generally accepted in the medical community.” This contractual structure provided insurers with significant flexibility when making coverage determinations, even though denying coverage could pad their bottom line. For this reason, lawmakers developed various tools to prevent insurers from exploiting their discretion to determine when care was “medically necessary” or “experimental.” These safeguards allowed insureds to challenge coverage denials internally within the insurance company, externally to an independent medical expert, and before courts via a contract law or ERISA cause of action. Additionally, state and federal mandates required insurers to cover specific medically necessary treatments and services. This Article documents a dramatic shift in health insurers’ contracts and practices from a standard-based approach to determining the medical and scientific appropriateness of health care towards a rule-based approach for making these determinations. It shows how health insurers have increasingly made incredibly detailed and specific rules of medical necessity part of their formal contractual obligations to policyholders. The Article then argues that health insurers’ shift from standards to rules for defining medically and scientifically appropriate health care undermines the effectiveness of traditional legal tools designed to constrain the risk of health insurer over-reaching. The Article concludes by exploring reforms that might effectively address the increasing rulification of medical necessity.","PeriodicalId":76903,"journal":{"name":"Employee benefits journal","volume":"14 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Employee benefits journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2139/SSRN.3777505","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3

Abstract

Health insurance contracts have long excluded coverage for care that is “experimental” or not “medically necessary.” Historically, insurance policies defined these key terms of coverage using broad standards. For example, “medically necessary” care might be defined as care that is “generally accepted in the medical community.” This contractual structure provided insurers with significant flexibility when making coverage determinations, even though denying coverage could pad their bottom line. For this reason, lawmakers developed various tools to prevent insurers from exploiting their discretion to determine when care was “medically necessary” or “experimental.” These safeguards allowed insureds to challenge coverage denials internally within the insurance company, externally to an independent medical expert, and before courts via a contract law or ERISA cause of action. Additionally, state and federal mandates required insurers to cover specific medically necessary treatments and services. This Article documents a dramatic shift in health insurers’ contracts and practices from a standard-based approach to determining the medical and scientific appropriateness of health care towards a rule-based approach for making these determinations. It shows how health insurers have increasingly made incredibly detailed and specific rules of medical necessity part of their formal contractual obligations to policyholders. The Article then argues that health insurers’ shift from standards to rules for defining medically and scientifically appropriate health care undermines the effectiveness of traditional legal tools designed to constrain the risk of health insurer over-reaching. The Article concludes by exploring reforms that might effectively address the increasing rulification of medical necessity.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
医疗需要规则
长期以来,医疗保险合同不包括“实验性”或“非医疗必要”的医疗服务。从历史上看,保险政策使用广泛的标准来定义这些关键的保险术语。例如,“医学上必要的”护理可能被定义为“在医学界普遍接受的”护理。这种合同结构为保险公司在确定承保范围时提供了极大的灵活性,即使拒绝承保可能会填补他们的底线。出于这个原因,立法者开发了各种工具来防止保险公司利用他们的自由裁量权来确定什么时候的护理是“医学上必要的”或“实验性的”。这些保障措施允许被保险人在保险公司内部、在外部向独立医疗专家提出质疑,并通过合同法或ERISA诉因向法院提出质疑。此外,州和联邦的规定要求保险公司承保特定的医疗必要治疗和服务。本文记录了健康保险公司的合同和实践的巨大转变,从基于标准的方法来确定医疗保健的医学和科学适当性,转向基于规则的方法来做出这些决定。它表明,健康保险公司如何越来越多地将医疗必要性的详细和具体规则作为其对保单持有人的正式合同义务的一部分。文章接着认为,健康保险公司从标准转向定义医学上和科学上适当的卫生保健的规则,破坏了旨在限制健康保险公司过度扩张风险的传统法律工具的有效性。文章最后探讨了可能有效解决医疗必需品日益增多的改革。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
A Proposal for Taking the Complexities Out of Taxing U.S. Retirement Distributions to Foreign Nationals Do Social Movements Spur Corporate Change? The Rise of “MeToo Termination Rights” in CEO Contracts Rules of Medical Necessity Does Employee Ownership Reduce Strike Risk? Evidence from U.S. Union Elections All that Glitters Is not Gold. Effects of Working from Home on Income Inequality at the Time of COVID-19
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1